Gabriel Morris
Director Financiero/CFO en IMMIX BIOPHARMA, INC. .
Fortuna: 1 M $ al 30/04/2024
Cargos activos de Gabriel Morris
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IMMIX BIOPHARMA, INC. | Director/Miembro de la Junta | 01/03/2021 | - |
Director Financiero/CFO | 01/03/2021 | - | |
Contacto de Relaciones con Inversores | 01/03/2021 | - | |
Alwaysraise LLC | Corporate Officer/Principal | 01/01/2020 | - |
Nexcella, Inc.
Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned. | Presidente | - | - |
Historial de carrera de Gabriel Morris
Antiguos cargos conocidos de Gabriel Morris.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Campbell & Co. LP
Campbell & Co. LP Investment ManagersFinance Campbell & Co. LP provides investments management services. It is a pioneer in absolute return investment management, specializing in systematic managed futures and equity market-neutral strategies. The company provides absolute return investment strategies and global diversification in a single investment. Campbell & Co was founded in 1972 and is located in Towson, MD. | Director de Operaciones | - | 03/01/2021 |
ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. Internet Software/ServicesTechnology Services Zap Surgical Systems, Inc. operates as a gyroscopic radiosurgery platform. The company was founded by John R. Adler and is headquartered in San Carlos, CA. | Director Financiero/CFO | 01/01/2019 | 01/01/2020 |
Formación de Gabriel Morris.
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Director of Finance/CFO | 2 |
Director/Board Member | 1 |
Investor Relations Contact | 1 |
Sectorial
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
IMMIX BIOPHARMA, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Campbell & Co. LP
Campbell & Co. LP Investment ManagersFinance Campbell & Co. LP provides investments management services. It is a pioneer in absolute return investment management, specializing in systematic managed futures and equity market-neutral strategies. The company provides absolute return investment strategies and global diversification in a single investment. Campbell & Co was founded in 1972 and is located in Towson, MD. | Finance |
ZAP Surgical Systems, Inc.
ZAP Surgical Systems, Inc. Internet Software/ServicesTechnology Services Zap Surgical Systems, Inc. operates as a gyroscopic radiosurgery platform. The company was founded by John R. Adler and is headquartered in San Carlos, CA. | Technology Services |
Alwaysraise LLC | |
Nexcella, Inc.
Nexcella, Inc. BiotechnologyHealth Technology Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned. | Health Technology |
- Bolsa de valores
- Insiders
- Gabriel Morris
- Experiencia